News
-
-
PRESS RELEASE
U.S. Defense Logistics Agency Exercises 1-Year Option Period in Applied DNA Counterfeit Mitigation Contract
Applied DNA Sciences announces $1.04 million contract with U.S. Defense Logistics Agency for counterfeit mitigation and product verification programs specific to FSC 5962 microcircuits. Continues support since 2014 -
-
PRESS RELEASE
Applied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform Economics
Applied DNA and Alphazyme announce successful conclusion of Linea RNAP manufacturing scale-up agreement, resulting in over 70% cost reduction and sufficient quantity for near-term demand. Partnership enhances Linea IVT platform profitability -
-
PRESS RELEASE
Applied DNA Partners with GenXys Health Care Systems to Deploy Clinical Decision Support System for Pharmacogenetic (PGx) Testing
Applied DNA partners with GenXys Health Care Systems to enhance precision prescribing decisions through TR8 PGx test. The partnership aims to improve patient outcomes and reduce healthcare costs -
-
PRESS RELEASE
Applied DNA Receives Approval for TR8(TM) Pharmacogenomic (PGx) Testing Service from New York State Department of Health
Applied DNA Sciences, Inc. receives approval from NYSDOH for TR8 PGx testing service targeting enterprise customers and healthcare networks in New York State, offering personalized medication guidance based on genetic testing -
-
